Stay updated on Bemcentinib in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Bemcentinib in AML/MDS Clinical Trial page.

Latest updates to the Bemcentinib in AML/MDS Clinical Trial page
- Check4 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov revision as v3.8.0 instead of v3.7.2. The study record content remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA general NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” was added above the 403 Forbidden page, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check39 days agoChange DetectedRemoval of the 403 Forbidden message and its HTML. The Home link in the footer was deleted, removing the previously visible blocked-access state and its navigation option from the page.SummaryDifference0.5%

- Check46 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the usual content with a minimal error page. This prevents users from viewing the trial details, locations, and related materials that are normally accessible on the record.SummaryDifference22%

- Check53 days agoChange DetectedA new page revision (v3.7.0) was added, replacing the previous revision (v3.6.6). This update represents a version bump to the page's underlying documentation/system without altering the displayed study details.SummaryDifference0.0%

Stay in the know with updates to Bemcentinib in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bemcentinib in AML/MDS Clinical Trial page.